Fund managers including Perennial Partners have invested in Micro-X Ltd (ASX:MX1).

The available fund manager commentary does not identify specific opportunities or catalysts for Micro-X. The only comment captured is Perennial Partners' September 2026 exit from the stock.

Perennial Partners exited its position in Micro-X in September 2026 after the stock was a negative contributor to performance, which points to weaker manager conviction. The commentary does not set out specific business risks. As a company commercialising new imaging technology across healthcare and security markets, Micro-X faces commercialisation and execution risk.

Rewrite the following description to be no more than 100 words. Optimise for SEO and AEO by prioritising clear, structured, and keyword-relevant language. Ensure the content is concise, factual, and useful for investors reviewing company and fund manager commentary. Do not include subjective opinions or add new information—only refine and restructure the existing content: Micro-X Limited engages in the design, development, manufacturing, and commercialization of imaging products for healthcare and security markets through cold cathode X-ray technology in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components; and electronic switching hardware and reconstruction software products. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; and imaging chains and custom X-ray imaging solutions, as well as engineering contract services and spare parts. The company has a strategic partnership with Billion Prima to develop and commercialize a baggage and parcel scanner product. Micro-X Limited was incorporated in 2011 and is based in Adelaide, Australia.